Fundz

Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer

PRIVATEMay 29, 2024

Position

Chief Business Officer

Company

Omega Therapeutics

Kaan Certel
CambridgeBiotechnologyHealth CareTherapeutics

Description

Omega Therapeutics announced the appointment of Kaan Certel, Ph.D., as Chief Business Officer. Dr. Certel will be responsible for global business development activities including strategic partnerships, bringing extensive biopharmaceutical industry experience to the company.

Quick answer

Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer (May 29, 2024). Omega Therapeutics is based in Cambridge, Massachusetts, United States.

Who is the new Chief Business Officer at Omega Therapeutics?
Omega Therapeutics named Kaan Certel Chief Business Officer, announced May 29, 2024.
What did Omega Therapeutics announce on May 29, 2024?
Omega Therapeutics announced the appointment of Kaan Certel, Ph.D., as Chief Business Officer. Dr. Certel will be responsible for global business development activities including strategic partnerships, bringing extensive biopharmaceutical industry experience to the company.
What does Omega Therapeutics do?
Omega Therapeutics is a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines to treat or cure a broad range of diseases.
Where is Omega Therapeutics based?
Omega Therapeutics is based in Cambridge, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
Alkeus Pharmaceuticals (May 29, 2024), bluebird bio (May 29, 2024), Aktis Oncology (May 30, 2024) and Tarsier Pharma (May 28, 2024) also announced leadership changes within 45 days of Omega Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Omega Therapeutics, and when

A new leader at Omega Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Omega Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Omega Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Omega Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Omega Therapeutics

Location

Cambridge, Massachusetts, United States

About

Omega Therapeutics is a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines to treat or cure a broad range of diseases. Omega is led by a seasoned and accomplished leadership team with a track record of innovation and operational excellence. The Company is committed to revolutionizing genomic medicine and has a pipeline of therapeutic candidates derived from its OMEGA platform spanning oncology, regenerative medicine, and multigenic diseases including inflammatory and cardiometabolic conditions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Omega Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Omega Therapeutics's next move

Learn about Strategic plan

Omega Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.